Posted On: 12/14/2014 11:11:23 AM
Post# of 72741
$JAZZ Recent Headlines
Why eBay is like a divorcee, and a pharma pick that’s setting up for a pop 8:46 a.m. Nov. 7, 2014 - Shawn Langlois
There’s good news for speculative growth traders 1:40 p.m. Sept. 2, 2014 - The Trading Deck
Speculators live by the sword, die by the sword 2:13 p.m. July 8, 2014 - The Trading Deck
Two reasons a top is not yet imminent 1:12 p.m. July 3, 2014 - The Trading Deck
Apple and Beats,Tesla and Missouri car dealers, plus the missing momo 7:36 a.m. May 9, 2014 - Barbara Kollmeyer
Jazz Pharmaceuticals swings to first-quarter loss 9:53 p.m. May 8, 2014 - MarketWatch.com
Dow industrials hesitate at major resistance 10:23 a.m. April 23, 2014 - Michael Ashbaugh
The case for the bears weakens 1:55 p.m. Feb. 25, 2014 - The Trading Deck
A stock that protects your identity and your portfolio 11:56 a.m. Feb. 3, 2014 - The Trading Deck
13 stocks set to outperform in 2014 from Sabrient's David Brown 7:21 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Sex bot on Volcker, dream gigs at Twitter and Wall Street's whiffs 8:27 a.m. Dec. 11, 2013 - Shawn Langlois
Dow industrials vie for all-time closing high 11:09 a.m. Nov. 21, 2013 - Michael Ashbaugh
One biotech that shouldn’t be missed 9:26 a.m. June 5, 2013 - The Trading Deck
Charting the S&P’s test of record territory 10:57 a.m. March 12, 2013 - Michael Ashbaugh
Charting the S&P’s test of record territory 10:51 a.m. March 12, 2013 - Michael Ashbaugh
S&P 500 nears next technical test 11:07 a.m. Nov. 30, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 11:11 a.m. Oct. 2, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 10:50 a.m. Oct. 2, 2012 - Michael Ashbaugh
4 stocks with charts pointing higher 5:58 a.m. Oct. 2, 2012 - The Trading Deck
Dow, Nasdaq hesitate at the range top 10:22 a.m. Sept. 24, 2012 - Michael Ashbaugh
Jazz kicks off Fast Track review process for VOD med 1:28 p.m. Dec. 12, 2014 - Seeking Alpha
Insider Trading Alert - JAZZ, ARE And SCLN Traded By Insiders 11:30 a.m. Dec. 12, 2014 - TheStreet.com
JAZZ Pharmaceuticals Slips After Dosing Issue on JZP-386 - Analyst Blog 2:39 p.m. Dec. 10, 2014 - Zacks.com
Pharmaceutical Giant Merck Buys Cubist Pharma 10:04 a.m. Dec. 9, 2014 - GuruFocus.com
Top Global Stocks: Jazz, Actavis In IBD's World List 5:39 p.m. Dec. 8, 2014 - Investors Business Daily
Jazz Pharmaceuticals (JAZZ) Starts Late-Stage Study on Xyrem - Analyst Blog 9:50 a.m. Dec. 3, 2014 - Zacks.com
Top Funds Gobble Up Tech And Medical Stocks 5:19 p.m. Dec. 2, 2014 - Investors Business Daily
Enrollment begins in Phase 3 trial for Xyrem expanded label 4:50 p.m. Dec. 2, 2014 - Seeking Alpha
Today's Momo Momentum Stock To Watch: Jazz Pharmaceuticals (JAZZ) 3:24 p.m. Nov. 26, 2014 - TheStreet.com
Insider Trading Alert - INTU, JAZZ And STNR Traded By Insiders 1:01 p.m. Nov. 26, 2014 - TheStreet.com
Riding The Bull Market With These 2 Momentum ETFs 2:10 p.m. Nov. 20, 2014 - Benzinga.com
Four International IBD 50 Stocks Near Buy Points 5:33 p.m. Nov. 19, 2014 - Investors Business Daily
Insider Trading Alert - JAZZ, SSS And PLKI Traded By Insiders 11:45 a.m. Nov. 19, 2014 - TheStreet.com
Five Ethical Drugmakers Keep Leadership Positions 5:27 p.m. Nov. 17, 2014 - Investors Business Daily
Growth Momentum Should Continue For This Pharmaceutical Company 9:50 p.m. Nov. 15, 2014 - GuruFocus.com
Is Jazz Pharmaceuticals (JAZZ) a Great Growth Stock? - Tale of the Tape 9:03 a.m. Nov. 14, 2014 - Zacks.com
Expect More Specialty Pharma Deals 7:40 a.m. Nov. 14, 2014 - Barrons.com
Sucampo-Takeda Sue Dr. Reddy's for Amitiza Patent Violation - Analyst Blog 4:30 p.m. Nov. 13, 2014 - Zacks.com
Update: Jazz Pharmaceuticals Q3 Earnings 11:00 a.m. Nov. 7, 2014 - Seeking Alpha
Jazz Pharmaceuticals Public Limited Company (JAZZ): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 5, 2014 - Zacks.com
Jazz Pharmaceuticals Initiates Rolling NDA Submission For Defibrotide For The Treatment Of Severe Hepatic Veno-Occlusive Disease 4:05 p.m. Dec. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals and Concert Pharmaceuticals Provide JZP-386 Program Update 8:30 a.m. Dec. 9, 2014 - BusinessWire - BZX
Jazz Pharmaceuticals Announces First Patients Enrolled in Phase 3 Trial of Xyrem® (Sodium Oxybate) In Children And Adolescents Who Have Narcolepsy With Cataplexy 4:05 p.m. Dec. 2, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals To Present New Analysis Of Defibrotide Data In Patients With Hepatic Veno-Occlusive Disease (VOD) At ASH Annual Meeting 4:05 p.m. Dec. 2, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 4:05 p.m. Nov. 25, 2014 - PR Newswire - PRF
Quarterly Financial Performance Reviews, Upcoming Events, and Medicare Plan Launch - Research Reports on Actavis, Celgene, UnitedHealth, Jazz and Endo 8:50 a.m. Nov. 10, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 4:05 p.m. Nov. 6, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Third Quarter 2014 Financial Results And Updated Guidance 4:05 p.m. Nov. 4, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals to Report 2014 Third Quarter Financial Results on November 4, 2014 3:05 p.m. Oct. 21, 2014 - PR Newswire - PRF
Positive Study Results, Dividend, Regulatory Warning, Board Statements, and Technical Updates - Research Reports on Regeneron, CVS Health, Valeant, Allergan and Jazz 8:15 a.m. Oct. 7, 2014 - PR Newswire - PRF
Positive Study Results, Market Activity, Acquisition Proposal, Earnings Schedules, and Collaboration - Research Reports on Avanir, Jazz, Alere, Intuitive Surgical and GSK 8:05 a.m. Sept. 18, 2014 - PR Newswire - PRF
Market Activity, Drug Approval, Upcoming Conference, and Presentation of Clinical Data - Research Reports on Jazz, Keryx, Vertex, WellPoint and GSK 8:15 a.m. Sept. 10, 2014 - PR Newswire - PRF
Positive Drug Results, Market Activity Updates, Sustainability Report, Acquisitions, and Plant Closure - Research Reports on Repros, Jazz, Ingersoll-Rand, Nokia and Duke Energy 8:10 a.m. Sept. 2, 2014 - PR Newswire - PRF
Health Care Sector Stocks on our Radar -- Pacific Biosciences of California, Thermo Fisher Scientific, Lexicon Pharma, Vical, and Jazz Pharma 7:50 a.m. Aug. 27, 2014 - PR Newswire - PRF
Appointments, Market Activity, Regulatory Approvals, and Rights Acquisition - Research Reports on Nike, Morgan Stanley, Regeneron, Zimmer and Jazz 8:00 a.m. Aug. 21, 2014 - PR Newswire - PRF
Box Powers Cloud Collaboration for Leading Life Sciences Organizations 11:00 a.m. Aug. 20, 2014 - BusinessWire - BZX
Critical Alerts For Kate Spade & Co, Canadian Solar, Jazz Pharmaceuticals, InterMune and Micron. Released By InvestorsObserver 8:31 a.m. Aug. 14, 2014 - PR Newswire - PRF
Product Launch, Technical Updates, Clinical Study Results, Completion of Tender Offer, and Financial Result - Research Reports on Medtronic, Covidien, Johnson & Johnson, Merck and Jazz 8:20 a.m. Aug. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes 5:30 a.m. Aug. 8, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Proposed Offering of $500 Million of Exchangeable Senior Notes 3:05 p.m. Aug. 6, 2014 - PR Newswire - PRF
Why eBay is like a divorcee, and a pharma pick that’s setting up for a pop 8:46 a.m. Nov. 7, 2014 - Shawn Langlois
There’s good news for speculative growth traders 1:40 p.m. Sept. 2, 2014 - The Trading Deck
Speculators live by the sword, die by the sword 2:13 p.m. July 8, 2014 - The Trading Deck
Two reasons a top is not yet imminent 1:12 p.m. July 3, 2014 - The Trading Deck
Apple and Beats,Tesla and Missouri car dealers, plus the missing momo 7:36 a.m. May 9, 2014 - Barbara Kollmeyer
Jazz Pharmaceuticals swings to first-quarter loss 9:53 p.m. May 8, 2014 - MarketWatch.com
Dow industrials hesitate at major resistance 10:23 a.m. April 23, 2014 - Michael Ashbaugh
The case for the bears weakens 1:55 p.m. Feb. 25, 2014 - The Trading Deck
A stock that protects your identity and your portfolio 11:56 a.m. Feb. 3, 2014 - The Trading Deck
13 stocks set to outperform in 2014 from Sabrient's David Brown 7:21 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Sex bot on Volcker, dream gigs at Twitter and Wall Street's whiffs 8:27 a.m. Dec. 11, 2013 - Shawn Langlois
Dow industrials vie for all-time closing high 11:09 a.m. Nov. 21, 2013 - Michael Ashbaugh
One biotech that shouldn’t be missed 9:26 a.m. June 5, 2013 - The Trading Deck
Charting the S&P’s test of record territory 10:57 a.m. March 12, 2013 - Michael Ashbaugh
Charting the S&P’s test of record territory 10:51 a.m. March 12, 2013 - Michael Ashbaugh
S&P 500 nears next technical test 11:07 a.m. Nov. 30, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 11:11 a.m. Oct. 2, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 10:50 a.m. Oct. 2, 2012 - Michael Ashbaugh
4 stocks with charts pointing higher 5:58 a.m. Oct. 2, 2012 - The Trading Deck
Dow, Nasdaq hesitate at the range top 10:22 a.m. Sept. 24, 2012 - Michael Ashbaugh
Jazz kicks off Fast Track review process for VOD med 1:28 p.m. Dec. 12, 2014 - Seeking Alpha
Insider Trading Alert - JAZZ, ARE And SCLN Traded By Insiders 11:30 a.m. Dec. 12, 2014 - TheStreet.com
JAZZ Pharmaceuticals Slips After Dosing Issue on JZP-386 - Analyst Blog 2:39 p.m. Dec. 10, 2014 - Zacks.com
Pharmaceutical Giant Merck Buys Cubist Pharma 10:04 a.m. Dec. 9, 2014 - GuruFocus.com
Top Global Stocks: Jazz, Actavis In IBD's World List 5:39 p.m. Dec. 8, 2014 - Investors Business Daily
Jazz Pharmaceuticals (JAZZ) Starts Late-Stage Study on Xyrem - Analyst Blog 9:50 a.m. Dec. 3, 2014 - Zacks.com
Top Funds Gobble Up Tech And Medical Stocks 5:19 p.m. Dec. 2, 2014 - Investors Business Daily
Enrollment begins in Phase 3 trial for Xyrem expanded label 4:50 p.m. Dec. 2, 2014 - Seeking Alpha
Today's Momo Momentum Stock To Watch: Jazz Pharmaceuticals (JAZZ) 3:24 p.m. Nov. 26, 2014 - TheStreet.com
Insider Trading Alert - INTU, JAZZ And STNR Traded By Insiders 1:01 p.m. Nov. 26, 2014 - TheStreet.com
Riding The Bull Market With These 2 Momentum ETFs 2:10 p.m. Nov. 20, 2014 - Benzinga.com
Four International IBD 50 Stocks Near Buy Points 5:33 p.m. Nov. 19, 2014 - Investors Business Daily
Insider Trading Alert - JAZZ, SSS And PLKI Traded By Insiders 11:45 a.m. Nov. 19, 2014 - TheStreet.com
Five Ethical Drugmakers Keep Leadership Positions 5:27 p.m. Nov. 17, 2014 - Investors Business Daily
Growth Momentum Should Continue For This Pharmaceutical Company 9:50 p.m. Nov. 15, 2014 - GuruFocus.com
Is Jazz Pharmaceuticals (JAZZ) a Great Growth Stock? - Tale of the Tape 9:03 a.m. Nov. 14, 2014 - Zacks.com
Expect More Specialty Pharma Deals 7:40 a.m. Nov. 14, 2014 - Barrons.com
Sucampo-Takeda Sue Dr. Reddy's for Amitiza Patent Violation - Analyst Blog 4:30 p.m. Nov. 13, 2014 - Zacks.com
Update: Jazz Pharmaceuticals Q3 Earnings 11:00 a.m. Nov. 7, 2014 - Seeking Alpha
Jazz Pharmaceuticals Public Limited Company (JAZZ): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 5, 2014 - Zacks.com
Jazz Pharmaceuticals Initiates Rolling NDA Submission For Defibrotide For The Treatment Of Severe Hepatic Veno-Occlusive Disease 4:05 p.m. Dec. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals and Concert Pharmaceuticals Provide JZP-386 Program Update 8:30 a.m. Dec. 9, 2014 - BusinessWire - BZX
Jazz Pharmaceuticals Announces First Patients Enrolled in Phase 3 Trial of Xyrem® (Sodium Oxybate) In Children And Adolescents Who Have Narcolepsy With Cataplexy 4:05 p.m. Dec. 2, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals To Present New Analysis Of Defibrotide Data In Patients With Hepatic Veno-Occlusive Disease (VOD) At ASH Annual Meeting 4:05 p.m. Dec. 2, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 4:05 p.m. Nov. 25, 2014 - PR Newswire - PRF
Quarterly Financial Performance Reviews, Upcoming Events, and Medicare Plan Launch - Research Reports on Actavis, Celgene, UnitedHealth, Jazz and Endo 8:50 a.m. Nov. 10, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 4:05 p.m. Nov. 6, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Third Quarter 2014 Financial Results And Updated Guidance 4:05 p.m. Nov. 4, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals to Report 2014 Third Quarter Financial Results on November 4, 2014 3:05 p.m. Oct. 21, 2014 - PR Newswire - PRF
Positive Study Results, Dividend, Regulatory Warning, Board Statements, and Technical Updates - Research Reports on Regeneron, CVS Health, Valeant, Allergan and Jazz 8:15 a.m. Oct. 7, 2014 - PR Newswire - PRF
Positive Study Results, Market Activity, Acquisition Proposal, Earnings Schedules, and Collaboration - Research Reports on Avanir, Jazz, Alere, Intuitive Surgical and GSK 8:05 a.m. Sept. 18, 2014 - PR Newswire - PRF
Market Activity, Drug Approval, Upcoming Conference, and Presentation of Clinical Data - Research Reports on Jazz, Keryx, Vertex, WellPoint and GSK 8:15 a.m. Sept. 10, 2014 - PR Newswire - PRF
Positive Drug Results, Market Activity Updates, Sustainability Report, Acquisitions, and Plant Closure - Research Reports on Repros, Jazz, Ingersoll-Rand, Nokia and Duke Energy 8:10 a.m. Sept. 2, 2014 - PR Newswire - PRF
Health Care Sector Stocks on our Radar -- Pacific Biosciences of California, Thermo Fisher Scientific, Lexicon Pharma, Vical, and Jazz Pharma 7:50 a.m. Aug. 27, 2014 - PR Newswire - PRF
Appointments, Market Activity, Regulatory Approvals, and Rights Acquisition - Research Reports on Nike, Morgan Stanley, Regeneron, Zimmer and Jazz 8:00 a.m. Aug. 21, 2014 - PR Newswire - PRF
Box Powers Cloud Collaboration for Leading Life Sciences Organizations 11:00 a.m. Aug. 20, 2014 - BusinessWire - BZX
Critical Alerts For Kate Spade & Co, Canadian Solar, Jazz Pharmaceuticals, InterMune and Micron. Released By InvestorsObserver 8:31 a.m. Aug. 14, 2014 - PR Newswire - PRF
Product Launch, Technical Updates, Clinical Study Results, Completion of Tender Offer, and Financial Result - Research Reports on Medtronic, Covidien, Johnson & Johnson, Merck and Jazz 8:20 a.m. Aug. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes 5:30 a.m. Aug. 8, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Proposed Offering of $500 Million of Exchangeable Senior Notes 3:05 p.m. Aug. 6, 2014 - PR Newswire - PRF
(0)
(0)
